Global Preventable Vaccines Market Research Report 2020

Global Preventable Vaccines Market Research Report 2020

Table of Contents
1 Preventable Vaccines Market Overview
1.1 Product Overview and Scope of Preventable Vaccines
1.2 Preventable Vaccines Segment by Type
1.2.1 Global Preventable Vaccines Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Adult Preventable Vaccines
1.2.3 Pediatric Preventable Vaccines
1.3 Preventable Vaccines Segment by Application
1.3.1 Preventable Vaccines Sales Comparison by Application: 2020 VS 2026
1.3.2 Bacterial Diseases
1.3.3 Virus Diseases
1.4 Global Preventable Vaccines Market Size Estimates and Forecasts
1.4.1 Global Preventable Vaccines Revenue 2015-2026
1.4.2 Global Preventable Vaccines Sales 2015-2026
1.4.3 Preventable Vaccines Market Size by Region: 2020 Versus 2026
2 Global Preventable Vaccines Market Competition by Manufacturers
2.1 Global Preventable Vaccines Sales Market Share by Manufacturers (2015-2020)
2.2 Global Preventable Vaccines Revenue Share by Manufacturers (2015-2020)
2.3 Global Preventable Vaccines Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Preventable Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Preventable Vaccines Market Competitive Situation and Trends
2.5.1 Preventable Vaccines Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Preventable Vaccines Players (Opinion Leaders)
3 Preventable Vaccines Retrospective Market Scenario by Region
3.1 Global Preventable Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Preventable Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Preventable Vaccines Market Facts & Figures by Country
3.3.1 North America Preventable Vaccines Sales by Country
3.3.2 North America Preventable Vaccines Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Preventable Vaccines Market Facts & Figures by Country
3.4.1 Europe Preventable Vaccines Sales by Country
3.4.2 Europe Preventable Vaccines Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Preventable Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Preventable Vaccines Sales by Region
3.5.2 Asia Pacific Preventable Vaccines Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Preventable Vaccines Market Facts & Figures by Country
3.6.1 Latin America Preventable Vaccines Sales by Country
3.6.2 Latin America Preventable Vaccines Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Preventable Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Preventable Vaccines Sales by Country
3.7.2 Middle East and Africa Preventable Vaccines Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Preventable Vaccines Historic Market Analysis by Type
4.1 Global Preventable Vaccines Sales Market Share by Type (2015-2020)
4.2 Global Preventable Vaccines Revenue Market Share by Type (2015-2020)
4.3 Global Preventable Vaccines Price Market Share by Type (2015-2020)
4.4 Global Preventable Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Preventable Vaccines Historic Market Analysis by Application
5.1 Global Preventable Vaccines Sales Market Share by Application (2015-2020)
5.2 Global Preventable Vaccines Revenue Market Share by Application (2015-2020)
5.3 Global Preventable Vaccines Price by Application (2015-2020)
6 Company Profiles and Key Figures in Preventable Vaccines Business
6.1 GlaxoSmithKline
6.1.1 Corporation Information
6.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GlaxoSmithKline Products Offered
6.1.5 GlaxoSmithKline Recent Development
6.2 Merck
6.2.1 Merck Preventable Vaccines Production Sites and Area Served
6.2.2 Merck Description, Business Overview and Total Revenue
6.2.3 Merck Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Merck Products Offered
6.2.5 Merck Recent Development
6.3 Novartis
6.3.1 Novartis Preventable Vaccines Production Sites and Area Served
6.3.2 Novartis Description, Business Overview and Total Revenue
6.3.3 Novartis Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Novartis Products Offered
6.3.5 Novartis Recent Development
6.4 Pfizer
6.4.1 Pfizer Preventable Vaccines Production Sites and Area Served
6.4.2 Pfizer Description, Business Overview and Total Revenue
6.4.3 Pfizer Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Pfizer Products Offered
6.4.5 Pfizer Recent Development
6.5 Sanofi
6.5.1 Sanofi Preventable Vaccines Production Sites and Area Served
6.5.2 Sanofi Description, Business Overview and Total Revenue
6.5.3 Sanofi Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Sanofi Products Offered
6.5.5 Sanofi Recent Development
6.6 Takeda Pharmaceutical
6.6.1 Takeda Pharmaceutical Preventable Vaccines Production Sites and Area Served
6.6.2 Takeda Pharmaceutical Description, Business Overview and Total Revenue
6.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Takeda Pharmaceutical Products Offered
6.6.5 Takeda Pharmaceutical Recent Development
6.7 Abbott
6.6.1 Abbott Preventable Vaccines Production Sites and Area Served
6.6.2 Abbott Description, Business Overview and Total Revenue
6.6.3 Abbott Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Abbott Products Offered
6.7.5 Abbott Recent Development
6.8 Roche
6.8.1 Roche Preventable Vaccines Production Sites and Area Served
6.8.2 Roche Description, Business Overview and Total Revenue
6.8.3 Roche Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Roche Products Offered
6.8.5 Roche Recent Development
6.9 AstraZeneca
6.9.1 AstraZeneca Preventable Vaccines Production Sites and Area Served
6.9.2 AstraZeneca Description, Business Overview and Total Revenue
6.9.3 AstraZeneca Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.9.4 AstraZeneca Products Offered
6.9.5 AstraZeneca Recent Development
6.10 Mitsubishi Tanabe Pharma
6.10.1 Mitsubishi Tanabe Pharma Preventable Vaccines Production Sites and Area Served
6.10.2 Mitsubishi Tanabe Pharma Description, Business Overview and Total Revenue
6.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Mitsubishi Tanabe Pharma Products Offered
6.10.5 Mitsubishi Tanabe Pharma Recent Development
6.11 Lupin
6.11.1 Lupin Preventable Vaccines Production Sites and Area Served
6.11.2 Lupin Preventable Vaccines Description, Business Overview and Total Revenue
6.11.3 Lupin Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Lupin Products Offered
6.11.5 Lupin Recent Development
6.12 Serum Institute of India
6.12.1 Serum Institute of India Preventable Vaccines Production Sites and Area Served
6.12.2 Serum Institute of India Preventable Vaccines Description, Business Overview and Total Revenue
6.12.3 Serum Institute of India Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Serum Institute of India Products Offered
6.12.5 Serum Institute of India Recent Development
6.13 LG Life Sciences
6.13.1 LG Life Sciences Preventable Vaccines Production Sites and Area Served
6.13.2 LG Life Sciences Preventable Vaccines Description, Business Overview and Total Revenue
6.13.3 LG Life Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.13.4 LG Life Sciences Products Offered
6.13.5 LG Life Sciences Recent Development
6.14 S K Chemicals
6.14.1 S K Chemicals Preventable Vaccines Production Sites and Area Served
6.14.2 S K Chemicals Preventable Vaccines Description, Business Overview and Total Revenue
6.14.3 S K Chemicals Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.14.4 S K Chemicals Products Offered
6.14.5 S K Chemicals Recent Development
6.15 Shenzhen Kangtai Biological Products
6.15.1 Shenzhen Kangtai Biological Products Preventable Vaccines Production Sites and Area Served
6.15.2 Shenzhen Kangtai Biological Products Preventable Vaccines Description, Business Overview and Total Revenue
6.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Shenzhen Kangtai Biological Products Products Offered
6.15.5 Shenzhen Kangtai Biological Products Recent Development
6.16 Sinovac Biotech
6.16.1 Sinovac Biotech Preventable Vaccines Production Sites and Area Served
6.16.2 Sinovac Biotech Preventable Vaccines Description, Business Overview and Total Revenue
6.16.3 Sinovac Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Sinovac Biotech Products Offered
6.16.5 Sinovac Biotech Recent Development
6.17 Janssen Pharmaceuticals
6.17.1 Janssen Pharmaceuticals Preventable Vaccines Production Sites and Area Served
6.17.2 Janssen Pharmaceuticals Preventable Vaccines Description, Business Overview and Total Revenue
6.17.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Janssen Pharmaceuticals Products Offered
6.17.5 Janssen Pharmaceuticals Recent Development
6.18 Crucell
6.18.1 Crucell Preventable Vaccines Production Sites and Area Served
6.18.2 Crucell Preventable Vaccines Description, Business Overview and Total Revenue
6.18.3 Crucell Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Crucell Products Offered
6.18.5 Crucell Recent Development
6.19 Bavarian Nordic
6.19.1 Bavarian Nordic Preventable Vaccines Production Sites and Area Served
6.19.2 Bavarian Nordic Preventable Vaccines Description, Business Overview and Total Revenue
6.19.3 Bavarian Nordic Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Bavarian Nordic Products Offered
6.19.5 Bavarian Nordic Recent Development
6.20 Baxter
6.20.1 Baxter Preventable Vaccines Production Sites and Area Served
6.20.2 Baxter Preventable Vaccines Description, Business Overview and Total Revenue
6.20.3 Baxter Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.20.4 Baxter Products Offered
6.20.5 Baxter Recent Development
6.21 Bharat Biotech
6.21.1 Bharat Biotech Preventable Vaccines Production Sites and Area Served
6.21.2 Bharat Biotech Preventable Vaccines Description, Business Overview and Total Revenue
6.21.3 Bharat Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.21.4 Bharat Biotech Products Offered
6.21.5 Bharat Biotech Recent Development
6.22 Dynavax
6.22.1 Dynavax Preventable Vaccines Production Sites and Area Served
6.22.2 Dynavax Preventable Vaccines Description, Business Overview and Total Revenue
6.22.3 Dynavax Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.22.4 Dynavax Products Offered
6.22.5 Dynavax Recent Development
6.23 Bausch Health
6.23.1 Bausch Health Preventable Vaccines Production Sites and Area Served
6.23.2 Bausch Health Preventable Vaccines Description, Business Overview and Total Revenue
6.23.3 Bausch Health Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.23.4 Bausch Health Products Offered
6.23.5 Bausch Health Recent Development
6.24 Protein Sciences
6.24.1 Protein Sciences Preventable Vaccines Production Sites and Area Served
6.24.2 Protein Sciences Preventable Vaccines Description, Business Overview and Total Revenue
6.24.3 Protein Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.24.4 Protein Sciences Products Offered
6.24.5 Protein Sciences Recent Development
6.25 Panacea Biotec
6.25.1 Panacea Biotec Preventable Vaccines Production Sites and Area Served
6.25.2 Panacea Biotec Preventable Vaccines Description, Business Overview and Total Revenue
6.25.3 Panacea Biotec Preventable Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.25.4 Panacea Biotec Products Offered
6.25.5 Panacea Biotec Recent Development
7 Preventable Vaccines Manufacturing Cost Analysis
7.1 Preventable Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Preventable Vaccines
7.4 Preventable Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Preventable Vaccines Distributors List
8.3 Preventable Vaccines Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Preventable Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Preventable Vaccines by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Preventable Vaccines by Type (2021-2026)
10.2 Preventable Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Preventable Vaccines by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Preventable Vaccines by Application (2021-2026)
10.3 Preventable Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Preventable Vaccines by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Preventable Vaccines by Region (2021-2026)
10.4 North America Preventable Vaccines Estimates and Projections (2021-2026)
10.5 Europe Preventable Vaccines Estimates and Projections (2021-2026)
10.6 Asia Pacific Preventable Vaccines Estimates and Projections (2021-2026)
10.7 Latin America Preventable Vaccines Estimates and Projections (2021-2026)
10.8 Middle East and Africa Preventable Vaccines Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Preventable Vaccines Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Preventable Vaccines Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Preventable Vaccines Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Preventable Vaccines Manufacturers Covered in This Study
Table 5. Global Preventable Vaccines Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Preventable Vaccines Sales Share by Manufacturers (2015-2020)
Table 7. Global Preventable Vaccines Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Preventable Vaccines Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Preventable Vaccines Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Preventable Vaccines Sales Sites and Area Served
Table 11. Manufacturers Preventable Vaccines Product Types
Table 12. Global Preventable Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Preventable Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preventable Vaccines as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Preventable Vaccines Players
Table 16. Global Preventable Vaccines Sales (K Units) by Region (2015-2020)
Table 17. Global Preventable Vaccines Sales Market Share by Region (2015-2020)
Table 18. Global Preventable Vaccines Revenue (Million US$) by Region (2015-2020)
Table 19. Global Preventable Vaccines Revenue Market Share by Region (2015-2020)
Table 20. North America Preventable Vaccines Sales by Country (2015-2020) (K Units)
Table 21. North America Preventable Vaccines Sales Market Share by Country (2015-2020)
Table 22. North America Preventable Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Preventable Vaccines Revenue Market Share by Country (2015-2020)
Table 24. Europe Preventable Vaccines Sales by Country (2015-2020) (K Units)
Table 25. Europe Preventable Vaccines Sales Market Share by Country (2015-2020)
Table 26. Europe Preventable Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Preventable Vaccines Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Preventable Vaccines Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Preventable Vaccines Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Preventable Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Preventable Vaccines Revenue Market Share by Region (2015-2020)
Table 32. Latin America Preventable Vaccines Sales by Country (2015-2020) (K Units)
Table 33. Latin America Preventable Vaccines Sales Market Share by Country (2015-2020)
Table 34. Latin America Preventable Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Preventable Vaccines Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Preventable Vaccines Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Preventable Vaccines Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Preventable Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Preventable Vaccines Revenue Market Share by Country (2015-2020)
Table 40. Global Preventable Vaccines Sales (K Units) by Type (2015-2020)
Table 41. Global Preventable Vaccines Sales Share by Type (2015-2020)
Table 42. Global Preventable Vaccines Revenue (Million US$) by Type (2015-2020)
Table 43. Global Preventable Vaccines Revenue Share by Type (2015-2020)
Table 44. Global Preventable Vaccines Price (USD/Unit) by Type (2015-2020)
Table 45. Global Preventable Vaccines Sales (K Units) by Application (2015-2020)
Table 46. Global Preventable Vaccines Sales Market Share by Application (2015-2020)
Table 47. Global Preventable Vaccines Sales Growth Rate by Application (2015-2020)
Table 48. GlaxoSmithKline Preventable Vaccines Corporation Information
Table 49. GlaxoSmithKline Description and Business Overview
Table 50. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. GlaxoSmithKline Main Product
Table 52. GlaxoSmithKline Recent Development
Table 53. Merck Preventable Vaccines Corporation Information
Table 54. Merck Corporation Information
Table 55. Merck Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Merck Main Product
Table 57. Merck Recent Development
Table 58. Novartis Preventable Vaccines Corporation Information
Table 59. Novartis Corporation Information
Table 60. Novartis Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Novartis Main Product
Table 62. Novartis Recent Development
Table 63. Pfizer Preventable Vaccines Corporation Information
Table 64. Pfizer Corporation Information
Table 65. Pfizer Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Pfizer Main Product
Table 67. Pfizer Recent Development
Table 68. Sanofi Preventable Vaccines Corporation Information
Table 69. Sanofi Corporation Information
Table 70. Sanofi Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Sanofi Main Product
Table 72. Sanofi Recent Development
Table 73. Takeda Pharmaceutical Preventable Vaccines Corporation Information
Table 74. Takeda Pharmaceutical Corporation Information
Table 75. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Takeda Pharmaceutical Main Product
Table 77. Takeda Pharmaceutical Recent Development
Table 78. Abbott Preventable Vaccines Corporation Information
Table 79. Abbott Corporation Information
Table 80. Abbott Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Abbott Main Product
Table 82. Abbott Recent Development
Table 83. Roche Preventable Vaccines Corporation Information
Table 84. Roche Corporation Information
Table 85. Roche Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Roche Main Product
Table 87. Roche Recent Development
Table 88. AstraZeneca Preventable Vaccines Corporation Information
Table 89. AstraZeneca Corporation Information
Table 90. AstraZeneca Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. AstraZeneca Main Product
Table 92. AstraZeneca Recent Development
Table 93. Mitsubishi Tanabe Pharma Preventable Vaccines Corporation Information
Table 94. Mitsubishi Tanabe Pharma Corporation Information
Table 95. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Mitsubishi Tanabe Pharma Main Product
Table 97. Mitsubishi Tanabe Pharma Recent Development
Table 98. Lupin Preventable Vaccines Corporation Information
Table 99. Lupin Corporation Information
Table 100. Lupin Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Lupin Main Product
Table 102. Lupin Recent Development
Table 103. Serum Institute of India Preventable Vaccines Corporation Information
Table 104. Serum Institute of India Corporation Information
Table 105. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Serum Institute of India Main Product
Table 107. Serum Institute of India Recent Development
Table 108. LG Life Sciences Preventable Vaccines Corporation Information
Table 109. LG Life Sciences Corporation Information
Table 110. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. LG Life Sciences Main Product
Table 112. LG Life Sciences Recent Development
Table 113. S K Chemicals Preventable Vaccines Corporation Information
Table 114. S K Chemicals Corporation Information
Table 115. S K Chemicals Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. S K Chemicals Main Product
Table 117. S K Chemicals Recent Development
Table 118. Shenzhen Kangtai Biological Products Preventable Vaccines Corporation Information
Table 119. Shenzhen Kangtai Biological Products Corporation Information
Table 120. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Shenzhen Kangtai Biological Products Main Product
Table 122. Shenzhen Kangtai Biological Products Recent Development
Table 123. Sinovac Biotech Preventable Vaccines Corporation Information
Table 124. Sinovac Biotech Corporation Information
Table 125. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Sinovac Biotech Main Product
Table 127. Sinovac Biotech Recent Development
Table 128. Janssen Pharmaceuticals Preventable Vaccines Corporation Information
Table 129. Janssen Pharmaceuticals Corporation Information
Table 130. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Janssen Pharmaceuticals Main Product
Table 132. Janssen Pharmaceuticals Recent Development
Table 133. Crucell Preventable Vaccines Corporation Information
Table 134. Crucell Corporation Information
Table 135. Crucell Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. Crucell Main Product
Table 137. Crucell Recent Development
Table 138. Bavarian Nordic Preventable Vaccines Corporation Information
Table 139. Bavarian Nordic Corporation Information
Table 140. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 141. Bavarian Nordic Main Product
Table 142. Bavarian Nordic Recent Development
Table 143. Baxter Preventable Vaccines Corporation Information
Table 144. Baxter Corporation Information
Table 145. Baxter Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 146. Baxter Main Product
Table 147. Baxter Recent Development
Table 148. Bharat Biotech Preventable Vaccines Corporation Information
Table 149. Bharat Biotech Corporation Information
Table 150. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 151. Bharat Biotech Main Product
Table 152. Bharat Biotech Recent Development
Table 153. Dynavax Preventable Vaccines Corporation Information
Table 154. Dynavax Corporation Information
Table 155. Dynavax Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 156. Dynavax Main Product
Table 157. Dynavax Recent Development
Table 158. Bausch Health Preventable Vaccines Corporation Information
Table 159. Bausch Health Corporation Information
Table 160. Bausch Health Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 161. Bausch Health Main Product
Table 162. Bausch Health Recent Development
Table 163. Protein Sciences Preventable Vaccines Corporation Information
Table 164. Protein Sciences Corporation Information
Table 165. Protein Sciences Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 166. Protein Sciences Main Product
Table 167. Protein Sciences Recent Development
Table 168. Panacea Biotec Preventable Vaccines Corporation Information
Table 169. Panacea Biotec Corporation Information
Table 170. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 171. Panacea Biotec Main Product
Table 172. Panacea Biotec Recent Development
Table 173. Sales Base and Market Concentration Rate of Raw Material
Table 174. Key Suppliers of Raw Materials
Table 175. Preventable Vaccines Distributors List
Table 176. Preventable Vaccines Customers List
Table 177. Market Key Trends
Table 178. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 179. Key Challenges
Table 180. Global Preventable Vaccines Sales (K Units) Forecast by Type (2021-2026)
Table 181. Global Preventable Vaccines Sales Market Share Forecast by Type (2021-2026)
Table 182. Global Preventable Vaccines Revenue (Million US$) Forecast by Type (2021-2026)
Table 183. Global Preventable Vaccines Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 184. Global Preventable Vaccines Sales (K Units) Forecast by Application (2021-2026)
Table 185. Global Preventable Vaccines Revenue (Million US$) Forecast by Application (2021-2026)
Table 186. Global Preventable Vaccines Sales (K Units) Forecast by Region (2021-2026)
Table 187. Global Preventable Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 188. Global Preventable Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 189. Global Preventable Vaccines Revenue Market Share Forecast by Region (2021-2026)
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Preventable Vaccines
Figure 2. Global Preventable Vaccines Sales Market Share by Type: 2020 VS 2026
Figure 3. Adult Preventable Vaccines Product Picture
Figure 4. Pediatric Preventable Vaccines Product Picture
Figure 5. Global Preventable Vaccines Consumption Market Share by Application: 2020 VS 2026
Figure 6. Bacterial Diseases
Figure 7. Virus Diseases
Figure 8. Global Preventable Vaccines Market Size 2015-2026 (US$ Million)
Figure 9. Global Preventable Vaccines Sales Capacity (K Units) (2015-2026)
Figure 10. Global Preventable Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Preventable Vaccines Sales Share by Manufacturers in 2020
Figure 12. Global Preventable Vaccines Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Preventable Vaccines Revenue in 2019
Figure 14. Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Preventable Vaccines Sales Market Share by Region (2015-2020)
Figure 16. Global Preventable Vaccines Sales Market Share by Region in 2019
Figure 17. Global Preventable Vaccines Revenue Market Share by Region (2015-2020)
Figure 18. Global Preventable Vaccines Revenue Market Share by Region in 2019
Figure 19. North America Preventable Vaccines Sales Market Share by Country in 2019
Figure 20. North America Preventable Vaccines Revenue Market Share by Country in 2019
Figure 21. U.S. Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 22. U.S. Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 24. Canada Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Preventable Vaccines Sales Market Share by Country in 2019
Figure 26. Europe Preventable Vaccines Revenue Market Share by Country in 2019
Figure 27. Germany Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 28. Germany Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 30. France Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 32. U.K. Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 36. Russia Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Preventable Vaccines Sales Market Share by Region in 2019
Figure 38. Asia Pacific Preventable Vaccines Revenue Market Share by Region in 2019
Figure 39. China Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 40. China Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 42. Japan Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 44. South Korea Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 46. India Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 48. Australia Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Preventable Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 54. Thailand Preventable Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysi

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs